Oral Antibiotics for Exposed Foot Tendon
For an exposed foot tendon, start with oral flucloxacillin 1g four times daily (or cephalexin as an alternative first-generation cephalosporin) to cover the most likely pathogens—Staphylococcus aureus and beta-hemolytic streptococci—which are the primary organisms in these soft tissue infections. 1
Antibiotic Selection Algorithm
First-Line Therapy (No Complicating Features)
- Flucloxacillin (cloxacillin) 1g four times daily, OR
- Cephalexin (first-generation cephalosporin) at standard dosing
These semisynthetic penicillinase-resistant penicillins and first-generation cephalosporins are the guideline-recommended empiric choices for mild-to-moderate infections where gram-positive cocci (GPC) are the usual pathogens 1. The 2024 IWGDF/IDSA guidelines specifically list these as first-line for uncomplicated presentations 1.
If Beta-Lactam Allergy or Intolerance
Switch to:
- Clindamycin, OR
- Fluoroquinolone (levofloxacin/moxifloxacin), OR
- Trimethoprim-sulfamethoxazole, OR
- Doxycycline 1
If Recent Antibiotic Exposure or Broader Coverage Needed
Consider:
- Amoxicillin-clavulanate (covers GPC + gram-negative rods), OR
- Fluoroquinolone (levofloxacin/moxifloxacin), OR
- Trimethoprim-sulfamethoxazole 1
If High Risk for MRSA
- Linezolid, OR
- Trimethoprim-sulfamethoxazole, OR
- Clindamycin (if local susceptibility patterns support) 1
Clinical Context and Evidence Strength
The guideline evidence strongly supports oral antibiotics as definitive therapy for foot infections, including those with exposed structures. Oral antibiotics have been demonstrated to be non-inferior to IV antibiotics for bone and joint infections overall 2, and this principle extends to diabetic foot infections when appropriate agents with high bioavailability and bone penetration are selected 2.
In the case example from the 2024 guidelines, a patient with deep foot infection near bone was successfully transitioned to oral flucloxacillin 1g four times daily after initial IV therapy, with complete resolution 3. This demonstrates that even infections involving deep structures respond well to oral therapy once source control is achieved.
Critical Considerations
Obtain cultures before starting antibiotics whenever possible—either wound swabs from the base of debrided tissue or tissue samples if surgical debridement is performed 3. This allows for targeted therapy adjustment if the empiric regimen doesn't cover the cultured organism.
Assess for infection severity markers:
- Systemic signs (fever, tachycardia, elevated WBC, elevated CRP) may warrant initial IV therapy with transition to oral once improving 3
- Probe-to-bone test—if positive, consider this osteomyelitis requiring longer duration (though still can use oral agents) 2
- Surrounding erythema >2cm, purulent discharge, or tissue necrosis may indicate moderate-to-severe infection
Common pitfalls to avoid:
- Don't assume exposed tendon automatically requires IV antibiotics—oral agents achieve excellent tissue penetration 2, 4
- Don't treat colonizers like Corynebacterium or coagulase-negative staphylococci unless clearly pathogenic 1
- Don't use tigecycline—it has been shown inferior to other options 1
- Avoid fluoroquinolones as first-line if other options available, given resistance concerns and side effect profile
Duration and Monitoring
Treat for 2 weeks minimum for soft tissue infection without bone involvement 3. If osteomyelitis is present, extend to 6 weeks or longer depending on surgical debridement adequacy 5.
Monitor clinical response within 48-72 hours—if no improvement, reassess for:
- Need for surgical debridement
- Resistant organisms requiring regimen change
- Deeper infection (osteomyelitis) requiring imaging
- Vascular insufficiency compromising antibiotic delivery
The key principle is that oral antibiotics with appropriate spectrum are equally effective as IV therapy for most foot infections, including those with exposed tendons, provided adequate source control and appropriate agent selection 1, 2.